Company Filing History:
Years Active: 2015-2018
Title: Kay Tye: Innovator in Optogenetics
Introduction
Kay Tye is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of neuroscience, particularly in the area of optogenetics. Her innovative work has led to the development of methods that enhance our understanding of brain function and behavior.
Latest Patents
Kay Tye holds 3 patents related to optically-controlled central nervous system (CNS) dysfunction. One of her latest patents involves animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain. This invention provides methods for producing these animals, wherein illumination of the light-responsive opsin proteins induces anxiety in the animal. Additionally, her patent outlines methods for alleviating and inducing anxiety in an animal, as well as methods for screening compounds that alleviate anxiety.
Career Highlights
Kay Tye is affiliated with Leland Stanford Junior University, where she continues her research and innovation in neuroscience. Her work has garnered attention for its potential applications in understanding and treating anxiety disorders.
Collaborations
Kay Tye has collaborated with notable scientists in her field, including Karl A. Deisseroth and Lief Fenno. These collaborations have further advanced the research and applications of optogenetics.
Conclusion
Kay Tye's contributions to neuroscience through her patents and research are paving the way for new treatments for anxiety and other CNS disorders. Her innovative spirit and dedication to science continue to inspire future advancements in the field.